2017 Press Releases

-Archives-

UMMS researchers receive amfAR grant to eliminate HIV reservoirs using gene editing

UMMS researchers receive amfAR grant to eliminate HIV reservoirs using gene editing

Jeremy Luban, MD, and Scot Wolfe, PhD, have received a grant from amfAR to explore using a powerful gene editing tool, CRISPR/Cpf1, to eradicate the HIV genome in its host. The researchers are hoping that Cpf1’s unique capacity to employ multiple RNA “guides” will outmaneuver the retrovirus.

Educational Recognition Awards, Last Lecture and Second Year Oath Ceremony will take place April 25

Educational Recognition Awards, Last Lecture and Second Year Oath Ceremony will take place April 25

David Hatem, MD, recipient of the 2016 Chancellor’s Medal for Distinguished Teaching, will deliver the Last Lecture on Tuesday, April 25, following the presentation of the 2017 Educational Recognition Awards. New this year, the event will include the Second Year Oath Ceremony for the School of Medicine Class of 2019.

Examining the role of the microbiome in the effectiveness of colorectal cancer treatment

Examining the role of the microbiome in the effectiveness of colorectal cancer treatment

A study by Marian Walhout, PhD, and colleagues, shows that C. elegans, fed a diet of E.coli bacteria, are 100 times more sensitive to the chemotherapy drug floxuridine, commonly used to treat colon cancer, than worms fed different bacteria. These findings suggest that the bacteria residing in your digestive tract may play an important role in your ability to respond to chemotherapy. Results of the study were published in Cell

UMass Medical School announces 2017 Commencement speaker, honorary degree recipients

UMass Medical School announces 2017 Commencement speaker, honorary degree recipients

At the 44th annual Commencement Exercises on Sunday, June 4, UMass Medical School will award honorary degrees to ground-breaking physician, scientist and academic health leader Valerie Montgomery Rice, MD; humanitarian and businessman Víctor Grífols, president of Grifols; and Patricia Donahoe, MD, a renowned pediatric surgeon and cancer researcher.

New study shows that antipsychotic medications can be reduced in dementia patients

New study shows that antipsychotic medications can be reduced in dementia patients

The use of antipsychotic medication in nearly 100 Massachusetts nursing homes was significantly reduced when staff members were trained to recognize challenging behaviors of cognitively impaired residents as communication of their unmet needs, according to a new study led by Jennifer Tjia, MD, MSCE.

UMass Medical School faculty appointed to endowed chairs

UMass Medical School faculty appointed to endowed chairs

UMass Medical School will invest three faculty members into newly endowed chairs and three more to existing endowed chairs, as approved by a vote of the UMass Board of Trustees at its April 12 meeting. Two of the newly funded chairs, to be held by Mark Johnson, MD, and Marian Walhout, PhD, were made possible through the generosity of Maroun Semaan, co-founder, director and president of Petrofac Group.

Job Dekker receives inaugural International Award from British Biochemical Society

Job Dekker receives inaugural International Award from British Biochemical Society

Job Dekker, PhD, has been recognized by the Biochemical Society, based in London, as the inaugural recipient of the International Award.

Michele Pugnaire, champion of medical education at UMMS, to step down from senior associate dean role

Michele Pugnaire, champion of medical education at UMMS, to step down from senior associate dean role

Michele P. Pugnaire, MD, will step down from the role of senior associate dean for educational affairs in July, according to an announcement by Dean Terence R. Flotte. 

Clinical trial of ketamine for treatment-resistant depression underway at UMass Medical School

Clinical trial of ketamine for treatment-resistant depression underway at UMass Medical School

UMass Medical School depression expert Anthony Rothschild, MD, is conducting a clinical trial of ketamine for patients with treatment-resistant depression.

Expert’s Corner: Javier Irazoqui researches communication between the gut and the nervous system

Expert’s Corner: Javier Irazoqui researches communication between the gut and the nervous system

Javier Elbio Irazoqui, PhD, associate professor of microbiology & physiological systems, is interested in fundamental mechanisms of innate immunity and inflammation.

Stay Connected with UMassMedNow

For the Media
▴ Back To Top
Section Menu To Top